The Department of Biomedicine

Mikroskopisk bilde av en nervecelle som ligner på en blomst

At the Department of Biomedicine, education and research center on the biological mechanisms of human health and disease.

We investigate molecular disease mechanisms and use our knowledge to develop new diagnostic tools and therapies. 
Our broad spectrum of expertise covers the topics of

  • cancer
  • neuroscience
  • physiology
  • protein biology
  • nanotechnology
  • neuropsychiatric disorders
  • cell biology

At the Department of Biomedicine, we train future scientists in a master's programme and a PhD research school. Around 200 employees form the core of the ten thematically grouped research groups. We manage three high-technology core facilities that are available to all higher education institutions in Norway. Our public academic lecture series BBB seminars started in 2003 and has become a valuable contribution to the Department's outreach programme.

Rat in the lab

Researchers discovered enzyme that may be linked to athletic performances

An animal model made at the University of Bergen brings may shed new light on an “old” molecule, carnosine.

Bilde av forskerne fra UiB og HelseBergen som er med på samarbeidet

Working together to develop Porphyria treatment

Professor Aurora Martinez at Institute for Biomedicine and MD Aasne K. Aarsand lead an interdisciplinary team developing new treatments of acute intermittent porphyria (AIP).

Pills spilling

Drug from BergenBio in clinical trial against COVID-19

UiB spin-off biotech company BergenBio announced that their drug bemcentinib is frast-tracked in a phase-II clinical trial as a potential treatment against COVID-19.

Research mobility
Toronto skyline

Diversity Our Strength

Have you ever considered doing a research stay abroad to broaden your scientific horizon? Postdoctor Sylvia Varland recently returned from a 2-year research stay at University of Toronto. Learn more about her scientific adventure and cultural experiences.

VEGF-B overexpressing heart is sensitized to develop heart failure in DOCA-salt hypertensive rats

VEGF-B: A more balanced approach to cardiac angiogenesis?

A new study undertaken at UiB does answer one set of questions, however, raises many more with regards to the potential use of specific VEGF isoforms in order to promote re-vascularisation in heart failure.


Core Facilities

MIC (Microscopic Imaging Centre)
PROBE (Proteomics Unit at the University of Bergen)
BiSS (Biophysics, Structural Biology, and Screening) 

Core facilities that are open to any higher education institution in Norway. The idea behind the core facility concept is to make sophisticated scientific equipment and highly specialized personnel available to a wide range of users. In turn, core facility users contribute financially to operational expenses through paying a set fee for services rendered.